Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe COPD”

551 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 551 results

Post-approval studies (Phase 4)Study completedNCT02424344
What this trial is testing

Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
AstraZeneca 267
Large-scale testing (Phase 3)Study completedNCT00677807
What this trial is testing

Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
COPD
Novartis 415
Not applicableLooking for participantsNCT06072690
What this trial is testing

Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease ModerateChronic Obstructive Pulmonary Disease SevereCardiovascular Diseases+1 more
Lithuanian University of Health Sciences 80
Not applicableStudy completedNCT07777497
What this trial is testing

Respiratory Therapist-Supported Home Noninvasive Ventilation in Stable Severe COPD Without Hypercapnia

Who this might be right for
COPD
Kaohsiung Medical University Chung-Ho Memorial Hospital 14
Not applicableStudy completedNCT00563745
What this trial is testing

Telemedicine for Patients With Chronic Respiratory Insufficiency

Who this might be right for
Chronic Respiratory Failure
Michele Vitacca 240
Not applicableNot Yet RecruitingNCT06379529
What this trial is testing

The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and Respiratory Events

Who this might be right for
COPD ExacerbationCOPDCardio/Pulm: Heart Failure
NuvoAir Medical PC 1,050
Not applicableUnknownNCT00627029
What this trial is testing

Evaluation of Programs of Coordinated Care and Disease Management

Who this might be right for
Congestive Heart FailureDiabetesCoronary Artery Disease+6 more
Mathematica Policy Research, Inc. 18,277
Testing effectiveness (Phase 2)Study completedNCT01176903
What this trial is testing

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Chiesi Farmaceutici S.p.A. 65
Post-approval studies (Phase 4)Study completedNCT00496470
What this trial is testing

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Who this might be right for
Chronic Obstructive Pulmonary Disease, COPD
AstraZeneca 660
Large-scale testing (Phase 3)Looking for participantsNCT06878261
What this trial is testing

Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 990
Not applicableStudy completedNCT01900873
What this trial is testing

Effects of Inspiratory Muscle Training on Dyspnea Perception During Exercise in Patients With COPD

Who this might be right for
COPDSevere Systemic Illness-induced Respiratory Muscle Wasting
KU Leuven 20
Not applicableStudy completedNCT02012101
What this trial is testing

Non-invasive Mechanical Ventilation as a Rescue Therapy to Relieve Dyspnea in Patients With Stable Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Guangzhou Institute of Respiratory Disease 18
Post-approval studies (Phase 4)Study completedNCT01186653
What this trial is testing

Effect on Adrenal Function of Budesonide Versus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Hull University Teaching Hospitals NHS Trust 22
Not applicableStudy completedNCT00151372
What this trial is testing

Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients

Who this might be right for
Pulmonary Disease, Chronic ObstructiveMajor Depression
Weill Medical College of Cornell University 141
Large-scale testing (Phase 3)UnknownNCT05213507
What this trial is testing

Inhaled Amikacin in Preventing AECOPD

Who this might be right for
COPDCOPD Exacerbation
Shanghai Zhongshan Hospital 136
Large-scale testing (Phase 3)Study completedNCT00056264
What this trial is testing

Safety and Efficacy of Infliximab (Remicade) in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseCOPD
Centocor, Inc. 234
Testing effectiveness (Phase 2)Study completedNCT01425814
What this trial is testing

Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 87
Large-scale testing (Phase 3)Study completedNCT01437397
What this trial is testing

Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 1,692
Large-scale testing (Phase 3)Study completedNCT02487498
What this trial is testing

Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 355
Large-scale testing (Phase 3)Study completedNCT01490125
What this trial is testing

The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 247
Next Page